RenovoRx, Inc. (RNXT)
NASDAQ: RNXT · Real-Time Price · USD
1.040
0.00 (0.00%)
At close: Nov 5, 2024, 4:00 PM
1.000
-0.040 (-3.85%)
After-hours: Nov 5, 2024, 4:31 PM EST

RenovoRx Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Selling, General & Admin
5.075.735.652.630.820.9
Research & Development
5.25.674.33.042.393
Operating Expenses
10.2711.49.955.673.23.9
Operating Income
-10.27-11.4-9.95-5.67-3.2-3.9
Interest Expense
----0.83-0.59-
Interest & Investment Income
0.230.110.06--0.06
Other Non Operating Income (Expenses)
1.931.0600.12-0.01-0.01
EBT Excluding Unusual Items
-8.11-10.23-9.89-6.39-3.8-3.84
Other Unusual Items
---0.06--
Pretax Income
-8.11-10.23-9.89-6.32-3.8-3.84
Net Income
-8.11-10.23-9.89-6.32-3.8-3.84
Net Income to Common
-8.11-10.23-9.89-6.32-3.8-3.84
Shares Outstanding (Basic)
15109522
Shares Outstanding (Diluted)
15109522
Shares Change (YoY)
59.27%13.69%73.50%135.64%1.69%-
EPS (Basic)
-0.54-0.99-1.09-1.21-1.72-1.76
EPS (Diluted)
-0.54-0.99-1.09-1.21-1.72-1.76
Free Cash Flow
-9.28-10.26-8.81-5.93-3.53-3.35
Free Cash Flow Per Share
-0.61-1.00-0.97-1.14-1.59-1.54
EBITDA
--11.39-9.94-5.66--
D&A For EBITDA
-0.010.010.01--
EBIT
-10.27-11.4-9.95-5.67-3.2-3.9
Source: S&P Capital IQ. Standard template. Financial Sources.